07:00 , Mar 16, 2015 |  BC Week In Review  |  Financial News

Collegium completes venture financing

Collegium Pharmaceutical Inc. , Canton, Mass.   Business: Drug delivery, Neurology, Inflammation   Date completed: 2015-03-10   Type: Venture financing   Raised: $50 million   Investors: TPG Biotech; RA Capital Management; Adage Capital Management; Rock...
01:34 , Mar 11, 2015 |  BC Extra  |  Financial News

Collegium raises $50M <span class="*Red-type+bold">

Collegium Pharmaceutical Inc. (Canton, Mass.) raised $50 million in a series D round led by new investor TPG Biotech. New investors RA Capital, Adage Capital, Rock Springs Capital, EcoR1 Capital, Eventide Asset Management and Aperture...
07:00 , Aug 6, 2012 |  BioCentury  |  Finance

Histogenics regeneration

Histogenics regeneration Sofinnova Ventures made its first regenerative medicine investment last month when it led a $49 million round that recapped Histogenics Corp. New investors Split Rock Partners; BioMed Ventures; and FinTech GIMV Fund participated...
07:00 , Jul 30, 2012 |  BC Week In Review  |  Financial News

Histogenics completes venture financing

Histogenics Corp. , Waltham, Mass.   Business: Musculoskeletal   Date completed: 7/24/12   Type: Venture financing   Raised: $49 million   Investors: Sofinnova Ventures; Split Rock Partners; BioMed Venture; FinTech GIMV Fund; ProChon Holdings; Altima...
01:52 , Jul 25, 2012 |  BC Extra  |  Financial News

Histogenics raises $49M in series A

Histogenics Corp. (Waltham, Mass.) raised $49 million in a series A round led by new investor Sofinnova Ventures. New investors Split Rock Partners; BioMed Ventures; and FinTech GIMV Fund participated along with existing investors ProChon...
07:00 , May 14, 2012 |  BC Week In Review  |  Company News

PreCision Dermatology, Triax Pharmaceuticals LLC deal

PreCision acquired the assets of Triax for an undisclosed sum. Triax markets branded prescription dermatology products, including Locoid , a mid-potency topical steroid, and acne treatments Minocin and Tretin X. PreCision's prescription dermatology subsidiary Onset...
08:00 , Feb 27, 2012 |  BC Week In Review  |  Financial News

Collegium completes venture financing

Collegium Pharmaceutical Inc. , Cumberland, R.I.   Business: Drug delivery, Neurology, Inflammation   Date completed: 2/22/12   Type: Venture financing   Raised: $22.5 million   Investors: Longitude Capital Management; Skyline Ventures; Frazier Healthcare Ventures; Boston...
00:50 , Feb 23, 2012 |  BC Extra  |  Financial News

Collegium raises $22.5M in series B

Collegium Pharmaceutical Inc. (Cumberland, R.I.) raised $22.5 million in a series B round led by Longitude Capital and Skyline Ventures. Existing investors Frazier Healthcare Ventures and Boston Millennia Partners participated. Longitude Capital's David Hirsch and...
00:28 , Jul 16, 2008 |  BC Extra  |  Financial News

Collegium raises $20 million

Collegium ( Cumberland , R.I.) raised $20 million in a series D round led by Frazier Healthcare Ventures. Existing investors Boston Millennia Partners and Westfield Capital also participated. Ferghana Partners was manager and advisor to...
07:00 , Oct 8, 2007 |  BioCentury  |  Finance

Ebb & Flow

MannKind (MNKD) has pushed itself closer to the top of a short list of biotech companies that have raised in excess of $1 billion without having a product on the market. Last week, the company...